Secondary Faculty

Shuji Ogino

Professor in the Department of Epidemiology

Epidemiology

Other Positions

Professor of Pathology

Pathology-Brigham and Women's Hospital

Harvard Medical School


Awards and Honors

Invited Nominator for Nobel Prize in Physiology or Medicine 2019, 2020, 20212019-2021
Nobel Committee

Highly Cited Researcher 2019, 2020, 20212019-2022
Clarivate Analytics

ASIP Outstanding Investigator Award2018
American Society for Investigative Pathology (ASIP)

Highly Cited Researcher2018
Clarivate Analytics

Runner-up for the Mentor-of-the-Year Award2018
Dana-Farber Cancer Institute

Highly Cited Researcher2017
Clarivate Analytics

Highly Cited Researcher2016
Thomson Reuters

Most Influential Scientific Minds2015
Thomson Reuters

NCI Outstanding Investigator Award (OIA)2015-2022
National Institute of Health (NIH)

Most Influential Scientific Minds2014
Thomson Reuters

ASCI Elected Member2014-pres
American Society for Clinical Investigation (ASCI)

Member, FASEB Excellence in Science Award Committee2014-pres
Federation of American Societies of Experimental Biology (FASEB)

AMP Meritorious Service Award2012
Association for Molecular Pathology (AMP)

USCAP Ramzi Cotran Young Investigator Award2011
United States and Canadian Academy of Pathology (USCAP)

AMP Executive Officer's Award2004
Association for Molecular Pathology (AMP)


Bibliography

Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.

Georgeson P, Steinfelder RS, Harrison TA, Pope BJ, Zaidi SH, Qu C, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Aglago EK, Berndt SI, Brenner H, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Dimou N, Doheny KF, Drew DA, Figueiredo JC, French AJ, Gallinger S, Giannakis M, Giles GG, Goode EL, Gruber SB, Gsur A, Gunter MJ, Harlid S, Hoffmeister M, Hsu L, Huang WY, Huyghe JR, Manson JE, Moreno V, Murphy N, Nassir R, Newton CC, Nowak JA, Obón-Santacana M, Ogino S, Pai RK, Papadimitrou N, Potter JD, Schoen RE, Song M, Sun W, Toland AE, Trinh QM, Tsilidis K, Ugai T, Um CY, Macrae FA, Rosty C, Hudson TJ, Winship IM, Phipps AI, Jenkins MA, Peters U, Buchanan DD.

medRxiv. 2024 Jan 30. PMID: 37090539

Epidemiologic factors in relation to colorectal cancer risk and survival by genotoxic colibactin mutational signature.

Thomas CE, Georgeson P, Qu C, Steinfelder RS, Buchanan DD, Song M, Harrison TA, Um CY, Hullar MA, Jenkins MA, Van Guelpen B, Lynch BM, Melaku YA, Huyghe JR, Aglago EK, Berndt SI, Boardman LA, Campbell PT, Cao Y, Chan AT, Drew DA, Figueiredo JC, French AJ, Giannakis M, Goode EL, Gruber SB, Gsur A, Gunter MJ, Hoffmeister M, Hsu L, Huang WY, Moreno V, Murphy N, Newcomb PA, Newton CC, Nowak JA, Obón-Santacana M, Ogino S, Sun W, Toland AE, Trinh QM, Ugai T, Zaidi SH, Peters U, Phipps AI.

Cancer Epidemiol Biomarkers Prev. 2024 Jan 22. PMID: 38252034


News

Cancer rising in people under 50  

Incidence of early onset cancers—including breast, colon, esophagus, kidney, liver, and pancreas—has been dramatically increasing around the world since 1990.